AI algorithms that can identify which patients are most likely to benefit from a drug recently backed for NHS use as a colorectal cancer (CRC) therapy have been developed by scien ...
IntroductionIn February 2022, BlackBasta emerged as a successor to Conti ransomware and quickly rose to prominence. BlackBasta was operational for three years until February 2025 when their internal ...
Personalis, Inc. , a leader in advanced genomics for precision oncology, today announced the successful presentation of clinical data at the American Association for Cancer Research (AACR) Annual ...
Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acceptance of 31 abstracts-including one oral presentation-for the ...
It’s an age-old story: an innovative robot company with a brilliant idea and some game-changing technology finds itself ...
Annual Symposium, Lunit (KRX:328130), a leading provider of AI for cancer diagnostics and precision oncology, today announced accelerating clinical adoption across the U.S., a full-scale enterprise ...
UK based provider of physical layer IP for 5G non-terrestrial networks (NTN), AccelerComm Ltd, today announced the grant of its 56th international patent, marking a significant milestone as the ...
If Google’s AI researchers had a sense of humor, they would have called TurboQuant, the new, ultra-efficient AI memory compression algorithm announced Tuesday, “Pied Piper” — or, at least that’s what ...
As Large Language Models (LLMs) expand their context windows to process massive documents and intricate conversations, they encounter a brutal hardware reality known as the "Key-Value (KV) cache ...
Even if you don’t know much about the inner workings of generative AI models, you probably know they need a lot of memory. Hence, it is currently almost impossible to buy a measly stick of RAM without ...
This important paper substantially advances our understanding of how Molidustat may work, beyond its canonical role, by identifying its therapeutic targets in cancer. This study presents a compelling ...
This study presents valuable findings by reanalyzing previously published MEG and ECoG datasets to challenge the predictive nature of pre-onset neural encoding effects. The evidence supporting the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results